SFX by Ex Libris Inc.

Title:	Endothelin
Source:	Cellular and Molecular Life Sciences [1420-682X] Kawanabe, Yoshifumi yr:2010

Basic

Full text

Full text available via SpringerLINK Contemporary 1997-Present

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Shah, R. "Endothelins in health and disease." European journal of internal medicine 18.4 (2007): 272-282.
description	2.	Jardim, C. "European respiratory update contemporary issues in pulmonary hypertension." European respiratory review 19.118 (2010): 266-271.
description	3.	Almodovar, Omar A. "Pulmonary Hypertension Associated With HIV Infection: Pulmonary Vascular Disease: The Global Perspective." Chest 137.20100600 (2010): 6-12.
description	4.	Flores, S. "Pulmonary Hypertension and HIV infection: epidemiology, pathogenesis, and clinical approach." Clinical microbiology and infection 17.1 (2010): 25-33.
description	5.	Martin, Paul D D. "An open-label, randomized, three-way crossover trial of the effects of coadministration of rosuvastatin and fenofibrate on the pharmacokinetic properties of rosuvastatin and fenofibric acid in healthy male volunteers." Clinical therapeutics 25.2 (2003): 459-471.
description	6.	Webb, David J. Basic & clinical pharmacology & toxicology 107 (2010): 58-.
description	7.	Wilkins, S L. "Basic science of pulmonary arterial hypertension for clinicians: New concepts and experimental therapies." Circulation. Heart failure 121.18 (2010): 2045-2066.
description	8.	Pankov, Y. "Hormones of the cardiovascular system." Journal of evolutionary biochemistry and physiology 40.2 (2004): 111-118.
description	9.	Weitzenblum, E. "Pulmonary hypertension in COPD." The European respiratory journal 32.5 (2008): 1371-85.
description	10.	BAYNASH, A G G. "INTERACTION OF ENDOTHELIN-3 WITH ENDOTHELIN-B RECEPTOR IS ESSENTIAL FOR DEVELOPMENT OF EPIDERMAL MELANOCYTES AND ENTERIC NEURONS." Cell 79.7 (1994): 1277-1285.
description	11.	Dembinski, R. "[Pulmonary hypertension]." Der Anaesthesist 55.2 (2006): 195-212.
description	12.	Keating, Katherine F M. "Fenofibrate: a review of its use in primary dyslipidaemia, the metabolic syndrome and type 2 diabetes mellitus." Drugs 67.1 (2007): 121-153.
description	13.	Tanoue, Lynn T T. "Pulmonary hypertension in the collagen vascular diseases." Seminars in respiratory and critical care medicine 30.4: 287-296.
description	14.	Sitbon, O. "Treat-to-target strategies in pulmonary arterial hypertension: the importance of using multiple goals." European respiratory review 19.118 (2010): 272-8.
description	15.	Lund, Amie K. "Human immunodeficiency virus- transgenic rats exhibit pulmonary hypertension." American journal of physiology. Lung cellular and molecular physiology 45.3 (2011).
description	16.	Pearson, S B. "The diagnosis and management of patients admitted to hospital with acute breathlessness." Postgraduate Medical Journal 57.669 (1981): 419-24.
description	17.	Shord, S. "Effects of oral clotrimazole troches on the pharmacokinetics of oral and intravenous midazolam." British journal of clinical pharmacology 69.2 (2010): 160-166.
description	18.	Wallin, B A A. "Lack of a clinically significant pharmacokinetic interaction between fenofibrate and pravastatin in healthy volunteers." The Journal of clinical pharmacology 40.3 (2000): 316-23.
description	19.	Baekken M, M. "Hypertension in an urban HIV-positive population compared with the general population: influence of combination antiretroviral therapy." Journal of hypertension 26.11 (2008): 2126-33.
description	20.	Mark T, G. "Pulmonary Complications of Sickle Cell Disease." New England Journal of Medicine, The 359.21 (2008): 2254-2265.